The Incubator
Rad BioMed Incubator is an endeavor uniquely positioned to tap the wealth of new life science technologies emerging from Israel’s academia, industry and private enterprise. The incubator provides physical infrastructure, seed capital (seed financing provided by the Chief Scientist Office and “matching” funding secured by the incubator’s owners), business development, and a wide range of related services to help entrepreneurs establish companies that will join the flourishing Israeli biomedical industry. Rad BioMed is owned by Mr. Yehuda Zisapel, President of the RAD Data Communications Group.
Rad BioMed is the natural interface between the world of biomedical research and the biomedical industry. It is the place where the seed of an innovative academic idea is given the chance to germinate and grow to a level that enables it to integrate into an industrial environment as a viable, self-sustained company.
Our goal is simple: to transform bio-science to bio-business.
Focusing on Life Science
Rad BioMed Incubator focuses solely on nurturing life science ventures. The special expertise and the extensive network of contacts developed through the years, enable it to support and promote fledgling start-ups from the entire range of the biomedical field including:
The mission of the Rad BioMed Incubator is to select cutting edge healthcare innovations and to nurture them into successful companies.